Clinical outcome of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy in locally advanced nasopharyngeal carcinoma: Comparative study at SKIMS Tertiary Care Institute

被引:6
|
作者
Fatima, Kaneez [1 ]
Andleeb, Asifa [1 ]
Sofi, Mushtaq Ahmad [1 ]
Rasool, Malik [1 ]
Fir, Afroz [1 ]
Nasreen, Shahida [1 ]
Dar, Nazir Ahmad [1 ]
机构
[1] Sheri Kashmir Inst Med Sci, Dept Radiat Oncol, Srinagar, Jammu And Kashm, India
关键词
Intensity-modulated radiotherapy; late toxicities; nasopharyngeal carcinoma; overall survival; two-dimensional conventional radiotherapy; RADIATION-THERAPY; HEAD; TOXICITIES; CHILDREN; TRISMUS; CANCER;
D O I
10.4103/jcrt.jcrt_169_21
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The management of nasopharyngeal cancer (NPC) at present is based primarily on radiotherapy, but the technique by which radiation therapy is delivered is different such as intensity-modulated radiotherapy (IMRT) and two-dimensional conventional radiotherapy (2D-CRT).Materials and Methods: In our study, IMRT and 2D-CRT were compared for their treatment outcome in locally advanced nasopharyngeal carcinoma (NPC) patients. Patients with Stage II to IVA nasopharyngeal cancer (NPC) as per the American Joint Committee on Cancer 7th and 8th edition 2017 treated with IMRT (n = 30) and 2D-CRT (n = 30) between October 2016 and October 2020 were retrospectively analyzed. We matched our patients by using the propensity-score matching method. OS was the primary endpoint of our study. The secondary endpoints were local relapse-free survival (LRFS), regional relapse-free survival (RRFS), disease-free survival (DFS), progression-free survival (PFS), and distant metastasis-free survival (DMFS). Acute and late radiation toxicities between IMRT and 2D-CRT were also compared.Results: In the propensity-matched cohort of 60 patients, 30 patients received 2D-CRT and 30 patients received IMRT. Compared with the treatment of 2D-CRT, the IMRT group is associated with a better 3-year OS (70% vs. 85% P = 0.045), LRFS (78% vs. 96% P = 0.047), RRFS (78% vs. 95% P = 0.015), DFS (80% vs. 95% P = 0.034), and PFS (84% vs. 90% P = 0.024), while as DMFS (85% vs. 85% P = 0.147) were comparable in both the groups. IMRT was also associated with a lower incidence of late toxicities such as xerostomia and trismus.Conclusion: Our study demonstrates that IMRT yields better long-term overall survival and local control including LRFS, RRFS, DFS, and PFS. In addition, late toxicities induced by irradiation in nasopharyngeal carcinoma (NPC) are lower with IMRT. IMRT may be an effective treatment in nasopharyngeal cancer (NPC) as compared to 2D-CRT, but further studies are needed to establish the association.
引用
收藏
页码:133 / 139
页数:7
相关论文
共 50 条
  • [31] CLINICAL OUTCOMES AND PATTERNS OF FAILURE AFTER INTENSITY-MODULATED RADIOTHERAPY FOR NASOPHARYNGEAL CARCINOMA
    Ng, Wai Tong
    Lee, Michael C. H.
    Hung, Wai Man
    Choi, Cheuk Wai
    Lee, Kin Chung
    Chan, Oscar S. H.
    Lee, Anne W. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (02): : 420 - 428
  • [32] Effect of adaptive replanning in patients with locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: a propensity score matched analysis
    Luo, Y.
    Qin, Y.
    Lang, J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (04) : 470 - 476
  • [33] A Multicentre UK Study of Outcomes of Nasopharyngeal Carcinoma Treated With Intensity-Modulated Radiotherapy ± Chemotherapy
    Slevin, F.
    Pan, S.
    Mistry, H.
    Sen, M.
    Foran, B.
    Slevin, N.
    Dixon, L.
    Thomson, D.
    Prestwich, R.
    CLINICAL ONCOLOGY, 2020, 32 (04) : 238 - 249
  • [34] A phase II study of concurrent cetuximab-cisplatin and intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinoma
    Ma, B. B. Y.
    Kam, M. K. M.
    Leung, S. F.
    Hui, E. P.
    King, A. D.
    Chan, S. L.
    Mo, F.
    Loong, H.
    Yu, B. K. H.
    Ahuja, A.
    Chan, A. T. C.
    ANNALS OF ONCOLOGY, 2012, 23 (05) : 1287 - 1292
  • [35] Sleep characteristics and psychological symptoms in patients with locally advanced nasopharyngeal carcinoma before and after intensity-modulated radiotherapy and concurrent chemotherapy
    Qin, Ling
    Mo, Yan-Lin
    Li, Ling
    Wei, Zhou-Ji
    Zhu, Xiao-Dong
    Yin, Xue
    Wei, Qing
    PSYCHOLOGY HEALTH & MEDICINE, 2015, 20 (06) : 662 - 669
  • [36] Long-Term Hearing Results and Otological Complications of Nasopharyngeal Carcinoma Patients: Comparison between Treatment with Conventional Two-Dimensional Radiotherapy and Intensity-Modulated Radiotherapy
    Tsang, Raymond K.
    Kwong, Dora L.
    Ho, Ambrose C.
    To, Victor S.
    Ho, Wai-Kuen
    Wei, William I.
    ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY HEAD AND NECK SURGERY, 2012, 74 (04): : 228 - 233
  • [37] A retrospective comparison of outcome and toxicity of preoperative image-guided intensity-modulated radiotherapy versus conventional pelvic radiotherapy for locally advanced rectal carcinoma
    Huang, Chun-Ming
    Huang, Ming-Yii
    Tsai, Hsiang-Lin
    Huang, Ching-Wen
    Ma, Cheng-Jen
    Lin, Chih-Hung
    Huang, Chih-Jen
    Wang, Jaw-Yuan
    JOURNAL OF RADIATION RESEARCH, 2017, 58 (02) : 247 - 259
  • [38] Phase II trial of neoadjuvant docetaxel and cisplatin followed by intensity-modulated radiotherapy with concurrent cisplatin in locally advanced nasopharyngeal carcinoma
    Zhong, Ya Hua
    Dai, Jing
    Wang, Xiao Yong
    Xie, Cong Hua
    Chen, Gang
    Zeng, Lei
    Zhou, Yun Feng
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (06) : 1577 - 1583
  • [39] Intensity-modulated radiotherapy plus nimotuzumab with or without concurrent chemotherapy for patients with locally advanced nasopharyngeal carcinoma
    Huang, Jianfeng
    Zou, Qinzhou
    Qian, Danqi
    Zhou, Leyuan
    Yang, Bo
    Chu, Jianjun
    Pang, Qingfeng
    Wang, Kewei
    Zhang, Fuzheng
    ONCOTARGETS AND THERAPY, 2017, 10 : 5835 - 5841
  • [40] Endoscopic surgery is superior to intensity-modulated radiotherapy in the treatment of advanced recurrent nasopharyngeal carcinoma
    Li, Wanpeng
    Zhang, Qianqian
    Chen, Fu
    Xu, Haoyuan
    Liu, Qiang
    Wang, Huan
    Zhang, Huankang
    Liu, Quan
    Gu, Yurong
    Li, Houyong
    Sun, Xicai
    Yu, Hongmeng
    Wang, Dehui
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2023, 13 (02) : 140 - 150